Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc reported a significant year-over-year increase in key financial metrics, with calculated billings growing nearly 44% to $671 million and revenue rising 46% to $170.7 million, well above consensus estimates. The company continues to expand its client base, reaching over 2,800 clients, and is expected to gain further market share in 2026 due to increasing utilization rates within its existing member pool. Despite operating expenses rising 30.4%, the revenue guidance for 2026 reflects a robust growth outlook, with expectations set between $732 million and $742 million, signaling continued financial strength and market demand for its services.

Bears say

Hinge Health Inc is facing a negative outlook primarily due to concerns about a macro-driven weak spending environment projected for the second half of 2025, which may lead to slower growth in fiscal year 2026. Although the company provided non-GAAP operating income guidance above consensus estimates, the reliance on employee utilization to drive billing growth presents added risks, potentially justifying a lower valuation multiple compared to peers. Furthermore, competitive pressures are anticipated, as evidenced by reports of clients delaying decisions due to budgetary constraints, suggesting that Hinge Health may struggle to secure new business in the near term.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $58.65, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $58.65, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.